Trailing twelve-month revenue
Company: Core Scientific
The claim, verbatim
Core Scientific's trailing twelve-month revenue is $440.3 million
Source (primary)
Core Scientific Director Elizabeth Crain Buys 6,000 Shares - The Motley Fool (-, news_article)
View cached copy (2026-09-04)Live source ↗Archive.org ↗
Quote: “Revenue (TTM) $440.3 million”
How we checked this
Checked on September 19, 2026. The cited source supports every part of this claim.
The document lists Revenue (TTM) of $440.3 million.
Confirmed in the source:
- Core Scientific's trailing twelve-month revenue is $440.3 million
What we did: Read our cached copy of the publisher (https://www.fool.com/coverage/filings/2026/09/03/core-scientific-director-elizabeth-crain-buys-6-000-shares/) in full (10,720 characters, retrieved September 4, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific Director Elizabeth Crain Buys 6,000 Shares - The Motley Fool
Quote: “Revenue (TTM) $440.3 million”